Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Efficacy of Phentolamine in Patients at High Risk of Contrast-Associated Acute Kidney Injury After Complex Percutaneous Coronary Intervention

NCT06286059 is registered in ClinicalTrials.gov with Helwan University as lead sponsor.

NCT NCT06286059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06286059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Efficacy of Phentolamine in Patients at High Risk of Contrast-Associated Acute Kidney Injury After Complex Percutaneous Coronary Intervention
Lead sponsor
Helwan University
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 7, 2024
Completion date
January 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, adrenergic receptor antagonist adverse reaction, ca-aki - contrast-associated acute kidney injury, coronary artery disease